Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Gut Microbiome and Symptomology in IBS: Mechanisms and Therapeutic Implications for Symptom Relief Through Prescribed Physical Activity in Clinical Practice

NCT06708533 is registered in ClinicalTrials.gov with Nottingham Trent University as lead sponsor.

NCT NCT06708533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06708533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Gut Microbiome and Symptomology in IBS: Mechanisms and Therapeutic Implications for Symptom Relief Through Prescribed Physical Activity in Clinical Practice
Lead sponsor
Nottingham Trent University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 31, 2025
Completion date
December 31, 2025
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome (ibs)